MedTrace Logo

Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility

NCT03104998 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2018-09-17

No results posted yet for this study

Summary

To study the effect of coenzyme Q10 on semen parameters in men with idiopathic infertility

Conditions

  • Idiopathic Infertility

Interventions

DRUG

Coenzyme Q10

200 mg of CoQ10 or placebo daily by mouth from day 1 till 26 weeks. CoQ10 treatment is safe, even at the highest doses cited in the literature. Most clinical trials have not reported significant adverse effects that necessitated stopping therapy. However, gastrointestinal effects such as abdominal discomfort, nausea, vomiting, diarrhea, and anorexia have occurred. Allergic rash and headache have also been reported

Sponsors & Collaborators

  • PharmEvo Pvt Ltd

    lead INDUSTRY

Principal Investigators

  • Masood Jawaid, MRCS,FCPS · PharmEvo Pvt Ltd

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-03-30
Completion
2018-05-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03104998 on ClinicalTrials.gov